Clopidogrel-statin interaction - Myth or reality?

被引：38
作者：
Angiolillo, Dominick J.
Alfonso, Fernando
机构：
[1] Univ Florida, Div Cardiol, Coll Med, Jacksonville, FL 32209 USA
[2] San Carlos Univ Hosp, Madrid, Spain
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 50卷 / 04期
关键词：
D O I：
10.1016/j.jacc.2007.04.041
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：296 / 298
页数：3
相关论文
共 21 条
  • [1] Platelet function assessment to predict outcomes after coronary interventions - Hype or hope?
    Alfonso, Fernando
    Angiolillo, Dominick J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (09) : 1751 - 1754
  • [2] Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease - Results of the Optimizing antiPlatelet Therapy In diabetes MellitUS (OPTIMUS) study
    Angiolillo, Dominick J.
    Shoemaker, Steven B.
    Desai, Bhaloo
    Yuan, Hang
    Charlton, Ronald K.
    Bernardo, Esther
    Zenni, Martin M.
    Guzman, Luis A.
    Bass, Theodore A.
    Costa, Marco A.
    [J]. CIRCULATION, 2007, 115 (06) : 708 - 716
  • [3] Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives
    Angiolillo, Dominick J.
    Fernandez-Ortiz, Antonio
    Bernardo, Esther
    Alfonso, Fernando
    Macaya, Carlos
    Bass, Theodore A.
    Costa, Marco A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (14) : 1505 - 1516
  • [4] Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment
    Angiolillo, Dominick J.
    Bernardo, Esther
    Ramirez, Celia
    Costa, Marco A.
    Sabate, Manel
    Jimenez-Quevedo, Pilar
    Hernandez, Rosana
    Moreno, Raul
    Escaned, Javier
    Alfonso, Fernando
    Banuelos, Camino
    Bass, Theodore A.
    Macaya, Carlos
    Fernandez-Ortiz, Antonio
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (02) : 298 - 304
  • [5] Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel
    Angiolillo, Dominick J.
    Fernandez-Ortiz, Antonio
    Bernardo, Esther
    Ramirez, Celia
    Cavallari, Ugo
    Trabetti, Elisabetta
    Sabate, Manel
    Hernandez, Rosana
    Moreno, Raul
    Escaned, Javier
    Alfonso, Fernando
    Banuelos, Camino
    Costa, Marco A.
    Bass, Theodore A.
    Pignatti, Pier Franco
    Macaya, Carlos
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (08) : 1895 - 1900
  • [6] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    Bhatt, DL
    Fox, KAA
    Hacke, W
    Berger, PB
    Black, HR
    Boden, WE
    Cacoub, P
    Cohen, EA
    Creager, MA
    Easton, JD
    Flather, MD
    Haffner, SM
    Hamm, CW
    Hankey, GJ
    Johnston, SC
    Mak, KH
    Mas, JL
    Montalescot, G
    Pearson, TA
    Steg, PG
    Steinhubl, SR
    Weber, MA
    Brennan, DM
    Fabry-Ribaudo, L
    Booth, J
    Topol, EJ
    Frye, RL
    Amarenco, P
    Brass, LM
    Buyse, M
    Cohen, LS
    DeMets, DL
    Fuster, V
    Hart, RG
    Marler, JR
    McCarthy, C
    Schoemig, A
    Lincoff, AM
    Brener, SJ
    Sila, CA
    Albuquerque, A
    Aroutiounov, G
    Artemiev, D
    Atkeson, BG
    Bartel, T
    Basart, DCG
    Lima, AB
    Belli, G
    Bordalo e Sa, AL
    Bosch, X
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) : 1706 - 1717
  • [7] A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention
    Brophy, James M.
    Babapulle, Mohan N.
    Costa, Vania
    Rinfret, Stephane
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (02) : 263 - 269
  • [8] Intensive versus moderate lipid lowering with statins after acute coronary syndromes
    Cannon, CP
    Braunwald, E
    McCabe, CH
    Rader, DJ
    Rouleau, JL
    Belder, R
    Joyal, SV
    Hill, KA
    Pfeffer, MA
    Skene, AM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) : 1495 - 1504
  • [9] The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin
    Clarke, TA
    Waskell, LA
    [J]. DRUG METABOLISM AND DISPOSITION, 2003, 31 (01) : 53 - 59
  • [10] Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation - A new drug-drug interaction
    Lau, WC
    Waskell, LA
    Watkins, PB
    Neer, CJ
    Horowitz, K
    Hopp, AS
    Tait, AR
    Carville, DGM
    Guyer, KE
    Bates, ER
    [J]. CIRCULATION, 2003, 107 (01) : 32 - 37
123